建行原副總裁章更生被提公訴 涉嫌受賄及違法放貸
中國最高人民檢察院網站顯示,中國建設銀行(00939.HK)(601939.SH)原黨委委員、副行長章更生涉嫌受賄、違法發放貸款一案,由國家監察委員會調查終結,經最高人民檢察院指定,由山東省淄博市人民檢察院審查起訴。近日,淄博市人民檢察院已向淄博市中級人民法院提起公訴。
檢察機關起訴指控,章更生利用擔任建行客戶部(營業部)總經理,黨委委員、副行長等職務上的便利,為相關單位和個人謀取利益,非法收受他人財物,數額特別巨大。章更生身為銀行工作人員,違反國家規定發放貸款,金額特別巨大且造成特別重大損失,依法應以收賄罪、違法發放貸款罪追究其刑事責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.